Transdermal Therapeutic Systems Market

Transdermal Therapeutic Systems (TTS) is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Transdermal Therapeutic Systems Market contains market size and forecasts of Transdermal Therapeutic Systems (TTS) in global, including the following market information:

• Global Transdermal Therapeutic Systems (TTS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Transdermal Therapeutic Systems (TTS) Market Sales, 2017-2022, 2023-2028, (M Units)
• Global top five Transdermal Therapeutic Systems (TTS) companies in 2021 (%)

The global Transdermal Therapeutic Systems (TTS) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Methyl Salicylate Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Transdermal Therapeutic Systems (TTS) include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Nitto Denko, Johnson & Johnson, Lohmann and Teikoku Seiyaku, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Transdermal Therapeutic Systems (TTS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transdermal Therapeutic Systems (TTS) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Transdermal Therapeutic Systems (TTS) Market Segment Percentages, by Type, 2021 (%)

• Methyl Salicylate
• Nitroglycerin
• Fentanyl
• Nicotine
• Rivastigmine
• Estradiol
• Others

Global Transdermal Therapeutic Systems (TTS) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Transdermal Therapeutic Systems (TTS) Market Segment Percentages, by Application, 2021 (%)

• OTC Channel
• Retail Channel
• E-Commerce Channel

Global Transdermal Therapeutic Systems (TTS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Transdermal Therapeutic Systems (TTS) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Transdermal Therapeutic Systems (TTS) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Transdermal Therapeutic Systems (TTS) revenues share in global market, 2021 (%)
• Key companies Transdermal Therapeutic Systems (TTS) sales in global market, 2017-2022 (Estimated), (M Units)
• Key companies Transdermal Therapeutic Systems (TTS) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Hisamitsu
• Mylan
• GSK
• Novartis
• Teve (Actavis)
• Nitto Denko
• Johnson & Johnson
• Lohmann
• Teikoku Seiyaku
• Pfizer
• Bayer
• Lingrui
• Sanofi
• UCB Pharma
• Dr. Reddy's Laboratories
• Qizheng
• Endo
• Mundipharma
• Huarun 999
• Haw Par
• Nichiban
• Mentholatum Company
• Laboratoires Genevrier
• Beijing Tide Pharmaceutical
• Luye Pharma Group